X0306
4
2022-07-07
0001099800
Edwards Lifesciences Corp
EW
0001710625
Lemercier Jean-Luc M
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, EMEA, Canada, Latin Amer
Common Stock
2022-07-07
4
A
0
6100.0000
0.0000
A
168874.8696
D
Employee Stock Option (Right to Acquire)
98.4300
2022-07-07
4
A
0
54500.0000
0.0000
A
2023-07-07
2029-07-06
Common Stock
54500.0000
54500.0000
D
Performance Rights
2022-07-07
4
A
0
7625.0000
0.0000
A
2025-07-07
Common Stock
7625.0000
7625.0000
D
These restricted stock units were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
These options were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.
Reflects the target number of shares (the Target Award) covered by restricted stock units granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on July 7, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.
Linda J. Park, Attorney-in-Fact
2022-07-11